Drug cos, investors keen to date India
India, long treated with suspicion by international drug companies because of its lax patent-protection laws, is looking newly attractive because of tighter laws, a vast potential market and a highly
India, long treated with suspicion by international drug companies because of its lax patent-protection laws, is looking newly attractive because of tighter laws, a vast potential market and a highly